U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503834) titled '"IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ"' on March 17.
Brief Summary: A prospective, open-label, uncontrolled, non-randomized, single-center Phase I/II clinical trial evaluating the safety of Anakinra in the immediate post-transplant period following pancreatic transplantation
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Pancreatic Transplant
Intervention:
DRUG: Anakinra 100Mg/0.67Ml Inj Syringe
Safety of Anakinra in the immediate aftermath of pancreatic transplantation
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Nantes University Hospital
Published by HT D...